Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation

American Journal of Cardiology

Volumn 113, Issue 5, 2014, Pages 851-859

  Ribeiro, Henrique B ^a   Urena, Marina ^a   Le Ven, Florent ^a   Nombela Franco, Luis ^a   Allende, Ricardo ^a   Clavel, Marie Annick ^a   Dahou, Abdellaziz ^a   Côté, Mélanie ^a   Laflamme, Jerôme ^a   Laflamme, Louis ^a   Delarochellière, Hugo ^a   Delarochellière, Robert ^a   Doyle, Daniel ^a   Dumont, Éric ^a   Bergeron, Sebastien ^a   Pibarot, Philippe ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; DIASTOLE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84893958245     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.11.038     Document Type: Article

References (30)

1. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
2. J. Bergler-Klein Natriuretic peptides in the management of aortic stenosis Curr Cardiol Rep 11 2009 85 93
3. J.L. Januzzi, and R. Troughton Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management Circulation 127 2013 500 507 discussion 508
4. M. Katz, F. Tarasoutchi, A.E. Pesaro, R.D. Lopes, G.S. Spina, M.L. Vieira, and M. Grinberg Natriuretic peptides and long-term mortality in patients with severe aortic stenosis J Heart Valve Dis 21 2012 331 336
5. J. Kefer, C. Beauloye, P. Astarci, J. Renkin, D. Glineur, A. Dekleermaeker, and J.L. Vanoverschelde Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation Am J Cardiol 106 2010 1782 1786
6. M.A. Sherif, M. Abdel-Wahab, O. Awad, V. Geist, G. El-Shahed, R. Semmler, M. Tawfik, A.A. Khattab, D. Richardt, G. Richardt, and R. Tolg Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation Am Heart J 160 2010 862 869
7. K. Spargias, S. Polymeros, A. Dimopoulos, A. Manginas, G. Pavlides, M. Balanika, A. Smirli, G. Stavridis, G. Dangas, and D.V. Cokkinos The predictive value and evolution of N-terminal pro-B-type natriuretic peptide levels following transcutaneous aortic valve implantation J Interv Cardiol 24 2011 462 469
8. D. Lopez-Otero, R. Trillo-Nouche, F. Gude, B. Cid-Alvarez, R. Ocaranza-Sanchez, M.S. Alvarez, P.V. Lear, and J.R. Gonzalez-Juanatey Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation Int J Cardiol 168 2013 1264 1268
9. Y. Elhmidi, S. Bleiziffer, N. Piazza, H. Ruge, M. Krane, M.A. Deutsch, I. Hettich, B. Voss, D. Mazzitelli, and R. Lange The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation J Invasive Cardiol 25 2013 38 44
10. R. Pfister, T. Wahlers, F.M. Baer, M. Scherner, J. Strauch, and E. Erdmann Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement Clin Res Cardiol 99 2010 301 307
11. J. Rodes-Cabau Transcatheter aortic valve implantation: current and future approaches Nat Rev Cardiol 9 2012 15 29
12. A.P. Kappetein, S.J. Head, P. Genereux, N. Piazza, N.M. van Mieghem, E.H. Blackstone, T.G. Brott, D.J. Cohen, D.E. Cutlip, G.A. van Es, R.T. Hahn, A.J. Kirtane, M.W. Krucoff, S. Kodali, M.J. Mack, R. Mehran, J. Rodes-Cabau, P. Vranckx, J.G. Webb, S. Windecker, P.W. Serruys, and M.B. Leon Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
13. H.N. Kim, and J.L. Januzzi Jr. Natriuretic peptide testing in heart failure Circulation 123 2011 2015 2019
14. P. Lancellotti, C. Tribouilloy, A. Hagendorff, L. Moura, B.A. Popescu, E. Agricola, J.L. Monin, L.A. Pierard, L. Badano, and J.L. Zamorano European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease) Eur J Echocardiogr 11 2010 223 244
15. N. Iwahashi, S. Nakatani, S. Umemura, K. Kimura, and M. Kitakaze Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis J Am Soc Echocardiogr 24 2011 984 991
16. N.O. Neverdal, C.W. Knudsen, T. Husebye, O.A. Vengen, J. Pepper, M. Lie, and T. Tonnessen The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up Eur J Heart Fail 8 2006 257 262
17. J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, H. Gabriel, T. Binder, R. Pacher, G. Maurer, and H. Baumgartner Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308
18. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Jr. Plasma brain natriuretic peptide concentration: impact of age and gender J Am Coll Cardiol 40 2002 976 982
19. S. Vickery, C.P. Price, R.I. John, N.A. Abbas, M.C. Webb, M.E. Kempson, and E.J. Lamb B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy Am J Kidney Dis 46 2005 610 620
20. F.A. McAlister, S. Stewart, S. Ferrua, and J.J. McMurray Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials J Am Coll Cardiol 44 2004 810 819
21. J. Rodes-Cabau, M. Gutierrez, R. Bagur, R. De Larochelliere, D. Doyle, M. Cote, J. Villeneuve, O.F. Bertrand, E. Larose, J. Manazzoni, P. Pibarot, and E. Dumont Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation J Am Coll Cardiol 57 2011 1988 1999
22. S.H. Poulsen, P. Sogaard, J.E. Nielsen-Kudsk, and H. Egeblad Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides J Am Soc Echocardiogr 20 2007 877 884
23. E. Vizzardi, A. D'Aloia, C. Fiorina, S. Bugatti, G. Parrinello, M. De Carlo, C. Giannini, V. Di Bello, A.S. Petronio, S. Curello, F. Ettori, and L. Dei Cas Early regression of left ventricular mass associated with diastolic improvement after transcatheter aortic valve implantation J Am Soc Echocardiogr 25 2012 1091 1098
24. M. Mok, M. Urena, L. Nombela-Franco, H.B. Ribeiro, R. Allende, R. Delarochelliere, D. Doyle, E. Dumont, M. Cote, and J. Rodes-Cabau Clinical and prognostic implications of existing and new-onset atrial fibrillation in patients undergoing transcatheter aortic valve implantation J Thromb Thrombolysis 35 2013 450 455
25. J. Rodes-Cabau, J.G. Webb, A. Cheung, J. Ye, E. Dumont, M. Osten, C.M. Feindel, M.K. Natarajan, J.L. Velianou, G. Martucci, B. DeVarennes, R. Chisholm, M. Peterson, C.R. Thompson, D. Wood, S. Toggweiler, R. Gurvitch, S.V. Lichtenstein, D. Doyle, R. DeLarochelliere, K. Teoh, V. Chu, K. Bainey, K. Lachapelle, A. Cheema, D. Latter, J.G. Dumesnil, P. Pibarot, and E. Horlick Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience J Am Coll Cardiol 60 2012 1864 1875
26. Z. Hijazi, J. Oldgren, A. Siegbahn, C.B. Granger, and L. Wallentin Biomarkers in atrial fibrillation: a clinical review Eur Heart J 34 2013 1475 1480
27. T.M. Sutton, R.A. Stewart, I.L. Gerber, T.M. West, A.M. Richards, T.G. Yandle, and A.J. Kerr Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation J Am Coll Cardiol 41 2003 2280 2287
28. S. Toggweiler, R.H. Boone, J. Rodes-Cabau, K.H. Humphries, M. Lee, L. Nombela-Franco, R. Bagur, A.B. Willson, R.K. Binder, R. Gurvitch, J. Grewal, R. Moss, B. Munt, C.R. Thompson, M. Freeman, J. Ye, A. Cheung, E. Dumont, D.A. Wood, and J.G. Webb Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation J Am Coll Cardiol 59 2012 2068 2074
29. J. Bergler-Klein, G. Mundigler, P. Pibarot, I.G. Burwash, J.G. Dumesnil, C. Blais, C. Fuchs, D. Mohty, R.S. Beanlands, Z. Hachicha, N. Walter-Publig, F. Rader, and H. Baumgartner B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study Circulation 115 2007 2848 2855
30. M.A. Clavel, P.V. Ennezat, S. Marechaux, J.G. Dumesnil, R. Capoulade, Z. Hachicha, P. Mathieu, A. Bellouin, S. Bergeron, P. Meimoun, M. Arsenault, T. Le Tourneau, A. Pasquet, C. Couture, and P. Pibarot Stress echocardiography to assess stenosis severity and predict outcome in patients with paradoxical low-flow, low-gradient aortic stenosis and preserved LVEF JACC Cardiovasc Imaging 6 2013 175 183